We therefore hypothesized that TRF likely alleviated NASH by regulating the circadian gene Per2 and ferroptosis and that this was ultimately related to the promotion of PPARα expression. The gene discussed is PPARA; the disease is metabolic dysfunction-associated steatohepatitis.